Hepatitis B antibody titer

It is usually reported as anti-HBs with a laboratory value and reference interpretation. The titer does not directly detect the virus and cannot alone diagnose active hepatitis B.

A result interpreted as protective may follow vaccination or recovery from infection. A result below the laboratory's protective threshold can mean that measurable antibody is low, but its significance varies with vaccination history, immune health and the reason testing was requested.

Surface antibody should not be confused with core antibody or surface antigen. Those markers answer different questions about prior exposure and current infection, so they may be ordered together when the clinical question extends beyond vaccine response.

Check whether the report names hepatitis B surface antibody and note the laboratory's own interpretation. Share the complete vaccine record, the timing of the most recent dose and any earlier titers with the requesting clinician.

Further action depends on why protection must be documented and whether the immune system is weakened. The clinician may recommend vaccination, another titer or broader hepatitis B testing; repeating doses without reviewing the record can create confusion.

Contact a healthcare service promptly after a needlestick, blood contact or possible sexual exposure. Do not wait for symptoms or rely on an old titer, because the clinician needs to assess the exposure, vaccination record and whether preventive treatment is appropriate.

Urgent evaluation is warranted for yellow eyes or skin, dark urine, persistent vomiting, severe upper abdominal pain, confusion or profound drowsiness. Fatigue alone has many causes and cannot reveal whether a titer is protective.

Ask whether the sample tested anti-HBs, how the laboratory classified the value, whether your vaccine history changes the interpretation, and whether surface antigen or core antibody testing is also needed.